- 2013
-
Press releases - 29.07.2013
Novel molecules to target the cytoskeleton
Teams from CNRS, the Université de Strasbourg and Inserm, led by Daniel Riveline1, Jean-Marie Lehn2 and Marie-France Carlier3, have synthesized molecules capable of causing rapid growth of actin networks, one of the components of the cytoskeleton.
-
What's on? - 29.07.2013
Return of the hot weather in France
For the last few days France has been experiencing high temperature peaks, reaching 40 degrees in certain regions. Even if from a meteorological point of view this is not classified as a heat wave, vigilance messages are multiplying and these are aimed at sections of the population that are most at risk, inviting them to […]
-
Press releases - 25.07.2013
How is the male genome preserved until it reaches the egg?
When the male genome carried in the spermatozoid leaves the male body to reach the egg, it undergoes numerous transformations. A team led by Saadi Khochbin in Mixed Research Unit 823 at the Institut Albert Bonniot Research Centre (Inserm/Joseph Fourier University) in Grenoble has described the molecular mechanisms that enable the transmission of the male genome to the egg.
-
What's on? - 19.07.2013
Sport and disability: a training plan for paraplegics
One year after the success of the Paralympic Games in London, France will be hosting the World Handisport Athletics Championships this Friday 19 July in Lyon (lasting until 28 July, the World Handisport Athletics Championships. In Dijon, Gaëlle Deley, scientific officer of the Centre d’Expertise de la Performance and associate researcher in Inserm Unit 1093 […]
-
Press releases - 19.07.2013
Pandoravirus : missing link discovered between viruses and cells
Researchers at IGS, the genomic and structural information laboratory (CNRS/Aix-Marseille University), working in association with the large-scale biology laboratory (CEA/Inserm/Grenoble Alpes University) have just discovered two giant viruses which, in terms of number of genes, are comparable to certain eukaryotes, microorganisms with nucleated cells.
-
Press releases - 14.07.2013
Boosting Muscle capacity
Une nouvelle cible pharmacologique permettant d’améliorer le fonctionnement du muscle vient d’être découverte chez la souris par l’équipe d’Hélène Duez, chargée de recherche à l’Inserm dans l’unité 1011 “Récepteurs nucléaires, maladies cardiovasculaires et diabète” (Inserm/Université Lille 2 droit et santé/Institut Pasteur de Lille) dirigée par Bart Staels.
-
Press releases - 12.07.2013
(French) : Découverte d’une nouvelle cible thérapeutique chez E. coli
Des chercheurs ont mis en évidence chez la bactérie Escherichia coli des interactions complexes entre les voies de biosynthèse de divers facteurs de virulence : la colibactine, une génotoxine potentiellement cancérigène, et les sidérophores, molécules impliquées dans la captation du fer qui est essentiel à la survie des bactéries.
-
Press releases - 11.07.2013
There is current over-treatment of prostate cancer in France
Research conducted by Cyrille Delpierre (INSERM Unit 1027 “Epidemiology and Public Health Analyses: Risks, Chronic Illness and Handicaps”) in collaboration with the French Cancer Registers Network assessed the proportion of patients potentially suffering from prostate cancer and currently over-diagnosed or over-treated in France. According to a study performed on 1840 patients, current over-treatment involves a considerable number of patients being treated for a cancerous tumour in what is known as Stage T1 (early tumours) and, to a lesser extent, patients suffering from tumours in stage T2 (more advanced tumours). These figures should be taken seriously because over-diagnosis or over-treatment can be associated with undesirable side effects such as impotence or incontinence.
-
What's on? - 11.07.2013
Bill about embryonic stem cells
The bill to end the ban on research into embryos and embryonic stem cells that was hotly disputed last March is being debated again today in the National Assembly. The status of the embryo is discussed. This type of research has been banned in France unless special permission is received. (Consult the list of research teams authorised […]
-
News in brief - 10.07.2013
Multiple sclerosis: a composite treatment to repair damaged nerve fibres
A team of researchers led by Brahim Nait Oumesmar, Inserm Research Director at the PITIE-SALPETRIERE NEUROSCIENCES RESEARCH CENTER (CRICM) in collaboration with the University of Luxembourg, has just discovered a new molecule capable of stimulating the repair of the myelin destroyed in experimental models of multiple sclerosis. This advance will be published in The Journal […]